Joshua Labaer

Biography

 Joshua LaBaer, MD, PhD, is the newly appointed director of the Virginia G. Piper Center for Personalized Diagnostics with in the Biodesign Institute at Arizona State University. He was also the founder and Director of the Institute of Proteomics at Harvard Medical School, and is a board certified oncologist in Massachusetts. He attended the University of California at Berkeley as an undergraduate and completed medical school and graduate school at the University of California, San Francisco, where he studied steroid regulation of DNA transcription and protein-DNA interactions. He completed his clinical studies at the Brigham and Women’s Hospital and a clinical fellowship in Oncology at the Dana-Farber Cancer Institute in Boston. He also pursued research interests at the Massachusetts General Hospital in Boston in the areas of breast cancer, mammalian cell cycle regulation and cell cycle checkpoint genes. Dr. LaBaer is the inventor of a new protein array technology called Nucleic Acid Programmable Protein Arrays (NAPPA). The NAPPA technology, first published in the July 2004 issue of the journal Science, provides a simple, cost-effective way to produce, as a single element of a microarray, freshly synthesized protein corresponding to any gene of known sequence. He currently holds an academic appointment through the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. The author of numerous publications, Dr. LaBaer is also an associate editor of the Journal of Proteome Research, a member of the Scientific Advisory Committee for the Proteome Society and a founding member of the Human Proteome Organization.

Research Interest

 Biochemistry